BetaGlue Technologies
About:
BetaGlue Technologies engages in research and offers anti-cancer products.
Website: https://www.betaglue.com/
Top Investors: Panakes Partners, Neva SGR, LIFTT, EIC Accelerator, Kairos Partners
Description:
Among the company's products is a beta-emitting adhesive that aids in the regulation of radioactive injection straight into tumors. It allows clinicians to help prevent problems after lung and liver biopsies and other localized treatments.
Total Funding Amount:
28M EUR
Estimated Revenue Range:
$1M to $10M
Headquarters Location:
Milano, Lombardia, Italy
Founded Date:
2009-01-01
Contact Email:
info(AT)betaglue.com
Founders:
Number of Employees:
11-50
Last Funding Date:
2024-06-06
IPO Status:
Private
Industries:
© 2025 bioDAO.ai